19th March 2019 Content supplied by: Co-Diagnostics, Inc.
CE Mark for Co-Diagnostics' Zika/Dengue/Chikungunya Multiplex Test
The Logix Smart™ ZDC Test from Co-Diagnostics has obtained CE mark regulatory clearance to be sold as an in vitro diagnostic (“IVD”) for the diagnosis of Zika, dengue, and chikungunya in accepting markets, and is now available for purchase from the Company’s Utah-based ISO-13485 facility.
The Declaration of Conformity for the Logix Smart ZDC test confirms that it meets the Essential Requirements of the European Community’s In-Vitro Diagnostic Medical Device Directive (IVDD 98/79/EC), allowing export and sales of the product to commence immediately to markets that accept a CE mark as valid IVD regulatory approval, pending any local product registration requirements. These markets include several countries across the Caribbean basin and Latin America in which the Company already has distribution agreements in place. Co-Diagnostics expects regulatory approval for such a high-demand test to facilitate the creation of additional sales and distribution opportunities in those areas.
Dwight Egan, Chief Executive Officer of Co-Diagnostics, commented, “Receiving the CE mark for our CoPrimer™-based multiplex ZDC assay is the capstone of the design, development, validation, and regulatory approval process, which was completed from start to finish in under 6 months. This highly-specific diagnostic for three harmful diseases at once is possible due to our patented CoPrimer design platform enabling a massive reduction in false positives, which is especially important—but notoriously more difficult—in multiplexed assays of related pathogens. The exceptional performance of the Logix Smart ZDC test and our efficient development process are both further validations of our technology, and of the quality of our dedicated personnel.
Co-Diagnostics’ Logix Smart ZDC Test functions via a single-step reverse transcriptase real-time polymerase chain reaction to identify and differentiate between the viral RNA of Zika, dengue (all 4 serotypes), and chikungunya. The three viruses are spread by the same Aedes mosquitos and have similar symptoms, including sever fever and joint pain, which has historically led to false diagnoses.
More information related to performance, distribution, or purchasing can be found at codiagnostics.com/products/diagnostic-solutions/logix-smart-zdc/
Date Published: 19th March 2019
Source article link: http://codiagnostics.com/co-diagnostics-ce-mark-for-zdc-multiplex/
Ames Software for ProtoCOL 3 Now
Cherwell Publishes Guide on Sterility